Doxycycline topical gel - Ology Bioservices

Drug Profile

Doxycycline topical gel - Ology Bioservices

Alternative Names: Doxycycline gel; Doxycycline hydrogel; Doxycycline monohydrate hydrogel; NanoDOX Hydrogel

Latest Information Update: 05 Oct 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nanotherapeutics
  • Developer Nanotherapeutics; Ology Bioservices
  • Class Antibacterials; Antimalarials; Small molecules; Tetracyclines
  • Mechanism of Action Protein 30S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Atopic dermatitis
  • No development reported Diabetic foot ulcer; Wounds

Most Recent Events

  • 02 Oct 2017 Nanotherapeutics is now called as Ology Bioservices
  • 18 May 2017 Phase-II clinical trials in Atopic dermatitis in USA (Topical) (NCT02910011)
  • 01 Sep 2016 University of Florida plans to initiate a phase II trial for Atopic dermatitis in USA (NCT02910011)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top